XML 23 R107.htm IDEA: XBRL DOCUMENT v3.20.1
Valuation and Qualifying Accounts and Reserves (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Feb. 01, 2020
Feb. 02, 2019
Feb. 03, 2018
Allowance for Doubtful Accounts      
Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at Beginning of Period $ 78 $ 99 $ 262
Charged to Costs & Expenses 992 122 411
Accounts Written Off or Deductions [1] 275 143 574
Balance at End of Period 795 78 99
Sales Reserves      
Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at Beginning of Period [2] 9,451 3,768 3,419
Charged to Costs & Expenses [2]   (19) (524)
Charged to Other Accounts [2],[3] 362,764 359,711 335,675
Accounts Written Off or Deductions [1],[2] 360,546 354,009 334,802
Balance at End of Period [2] 11,669 9,451 3,768
Valuation allowances on deferred tax assets      
Valuation and Qualifying Accounts Disclosure [Line Items]      
Balance at Beginning of Period 10,268 8,376 7,388
Charged to Other Accounts [3] (426) 1,892 988
Balance at End of Period $ 9,842 $ 10,268 $ 8,376
[1] Actual returns and allowances.
[2] During Fiscal 2018, the Company adopted ASU 2014-09, “Revenue from Contracts with Customers,” which requires the Company’s sales return reserve to be established at the gross sales value with an asset established for the value of the expected merchandise returned. The liability and asset related to the sales return reserve were $11.7 million and $7.0 million, respectively, as of February 1, 2020, and $9.5 million and $5.7 million, respectively, as of February 2, 2019, and were included in the lines “Other current liabilities” and “Prepaid and other current assets,” respectively, on the Company’s Consolidated Balance Sheet. Prior period amounts have not been adjusted. As of February 3, 2018, the net sales return reserve was $3.8 million and was included in the line “Other current liabilities” on the Company’s Consolidated Balance Sheet.
[3] Amounts related to sales reserves are charged to net sales and cost of sales, and amounts related to valuation allowances on deferred taxes are charged to income tax expense.